Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term, Follow-up Study of Subjects Who Completed Phase III Trials ATX-101-10-16 or ATX-101-10-17 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT03682471 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT03682471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03682471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term, Follow-up Study of Subjects Who Completed Phase III Trials ATX-101-10-16 or ATX-101-10-17 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Lead sponsor
Allergan
Phase
Observational
Overall status
Completed
Start date
February 14, 2012
Completion date
December 13, 2013
Enrollment
201 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

subcutaneous fat